Protecting human subjects in neurosurgical trials: the challenge of psychogenic dystonia

Katrina A Bramstedt1, Paul J Ford

  • 1Research Subject Advocate Program, Cleveland Clinic, General Clinical Research Center, OH 44195, USA. txbioethics@yahoo.com

Insights

Psychogenic dystonia should be excluded from deep brain stimulation (DBS) trials. Due to diagnostic challenges, careful patient selection is crucial for neurosurgery research safety and ethical integrity.

Area of Science:

  • Neurosurgery
  • Neurology
  • Medical Ethics

Background:

  • Medically refractory organic dystonia causes significant suffering, driving research into surgical interventions like pallidotomy and deep brain stimulation (DBS).
  • Surgical trials necessitate stringent subject protection, emphasizing the importance of excluding inappropriate candidates to ensure welfare and trial integrity.

Purpose of the Study:

  • To advocate for the exclusion of psychogenic dystonia as an indication for deep brain stimulation (DBS) and neurosurgery.
  • To highlight the diagnostic and therapeutic challenges posed by psychogenic dystonia.

Main Methods:

  • Literature review and ethical analysis regarding patient selection for neurosurgical trials.
  • Discussion of the complexities in diagnosing psychogenic dystonia.

Main Results:

  • Psychogenic dystonia presents diagnostic and treatment difficulties, making it unsuitable for current DBS therapy.
  • The absence of a definitive diagnostic test for psychogenic dystonia complicates exclusion criteria development.

Conclusions:

  • Exclusion criteria for DBS and neurosurgery trials must be carefully established, particularly for conditions like psychogenic dystonia.
  • Fair and just criteria are needed to exclude patients with suspected psychogenic dystonia from surgical interventions.